• Tracy Fenner
• June 12, 2026
• Training & Education
• 0 Comments

The biopharmaceutical industry continues to evolve as manufacturers seek more efficient, scalable, and cost-effective ways to produce life-saving therapies. One of the most significant advancements driving this transformation is Continuous Upstream Processing (CUP), a modern approach that replaces traditional batch and fed-batch manufacturing methods with continuous culture and feeding strategies. As demand for biologics, cell therapies, and advanced therapeutics continues …